HALL LAURIE J TRUSTEE - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 325 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
HALL LAURIE J TRUSTEE ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$4
-100.0%
115
-37.8%
0.00%
-50.0%
Q3 2022$8,000
-20.0%
185
-31.5%
0.00%
-20.0%
Q2 2022$10,0000.0%2700.0%0.01%
+25.0%
Q1 2022$10,000
+25.0%
2700.0%0.00%
+33.3%
Q4 2021$8,000
-11.1%
2700.0%0.00%0.0%
Q3 2021$9,000
-47.1%
270
-37.2%
0.00%
-50.0%
Q2 2021$17,000
-61.4%
430
-56.1%
0.01%
-64.7%
Q1 2021$44,000
-20.0%
9800.0%0.02%
-22.7%
Q4 2020$55,000
+17.0%
9800.0%0.02%
+4.8%
Q3 2020$47,000
-7.8%
980
+16.7%
0.02%
-12.5%
Q4 2019$51,000
+8.5%
840
+6.3%
0.02%0.0%
Q3 2019$47,000
-7.8%
7900.0%0.02%
-7.7%
Q2 2019$51,000
-21.5%
790
-1.2%
0.03%
-23.5%
Q1 2019$65,000
+35.4%
8000.0%0.03%
+30.8%
Q4 2018$48,000
+9.1%
800
-5.9%
0.03%
+13.0%
Q3 2018$44,000
+25.7%
8500.0%0.02%
+15.0%
Q2 2018$35,000
-5.4%
8500.0%0.02%
-13.0%
Q1 2018$37,000
-14.0%
8500.0%0.02%
-4.2%
Q4 2017$43,000
-99.9%
850
-14.1%
0.02%
-22.6%
Q3 2017$50,193,000
-0.3%
9900.0%0.03%
-3.1%
Q2 2017$50,361,000
+34.2%
9900.0%0.03%
+33.3%
Q1 2017$37,531,000
+79753.2%
9900.0%0.02%
-20.0%
Q4 2016$47,000
+56.7%
990
-17.5%
0.03%
+50.0%
Q2 2016$30,000
+30.4%
1,200
+130.8%
0.02%
+42.9%
Q1 2016$23,0005200.01%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,510,173$159,221,4478.52%
Bellevue Group AG 9,233,700$418,840,6326.75%
Deep Track Capital, LP 2,834,069$128,553,3704.96%
BVF INC/IL 4,004,613$181,649,2464.90%
Sicart Associates LLC 203,132$9,214,0683.61%
Camber Capital Management LP 2,250,000$102,0603.36%
Privium Fund Management B.V. 228,493$10,364,4433.08%
Orbimed Advisors 2,169,500$98,408,5202.09%
SECTOR GAMMA AS 165,616$7,512,3421.92%
TANAKA CAPITAL MANAGEMENT INC 14,612$6631.89%
View complete list of IONIS PHARMACEUTICALS INC shareholders